SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-743948
Filing Date
2016-10-21
Accepted
2016-10-21 17:02:32
Documents
5
Period of Report
2016-10-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d271266d8k.htm 8-K 17912
2 EX-1.1 d271266dex11.htm EX-1.1 167767
3 EX-5.1 d271266dex51.htm EX-5.1 12146
4 GRAPHIC g271266g24q53.jpg GRAPHIC 6437
5 GRAPHIC g271266g44p32.jpg GRAPHIC 5454
  Complete submission text file 0001193125-16-743948.txt   215513
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 161946719
SIC: 2834 Pharmaceutical Preparations